Argus Investors' Counsel, Inc. Eli Lilly & CO Transaction History

Argus Investors' Counsel, Inc.

$148 Million
Q3 2024

A detailed history of Argus Investors' Counsel, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Argus Investors' Counsel, Inc. holds 5,274 shares of LLY stock, worth $4.16 Million. This represents 3.15% of its overall portfolio holdings.

Number of Shares

5,274

Previous 8,273 36.25%

Holding current value

$4.16 Million

Previous $7.49 Million 37.62%

% of portfolio

3.15%

Previous 4.67%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$772.14 - $960.02 $2.32 Million - $2.88 Million	-2,999 Reduced 36.25%	5,274 $4.67 Million
Q2 2024 Jul 22, 2024	BUY	$724.87 - $909.04 $1.56 Million - $1.95 Million	2,147 Added 35.05%	8,273 $7.49 Million
Q2 2024 Jul 19, 2024	SELL	$724.87 - $909.04 $1.05 Million - $1.32 Million	-1,455 Reduced 19.19%	6,126 $5.55 Million
Q1 2024 Apr 24, 2024	BUY	$592.2 - $792.28 $438,228 - $586,287	740 Added 10.82%	7,581 $5.9 Million
Q4 2023 Jan 26, 2024	BUY	$525.19 - $619.13 $2,100 - $2,476	4 Added 0.06%	6,841 $3.99 Million
Q4 2023 Jan 19, 2024	SELL	$525.19 - $619.13 $488,951 - $576,410	-931 Reduced 11.99%	6,837 $3.99 Million
Q3 2023 Oct 17, 2023	BUY	$434.7 - $599.3 $26,082 - $35,958	60 Added 0.78%	7,768 $4.17 Million
Q2 2023 Jul 20, 2023	SELL	$350.74 - $468.98 $340,568 - $455,379	-971 Reduced 11.19%	7,708 $3.61 Million
Q1 2023 Apr 20, 2023	SELL	$310.63 - $364.82 $17,395 - $20,429	-56 Reduced 0.64%	8,679 $2.98 Million
Q4 2022 Jan 18, 2023	SELL	$321.55 - $374.67 $43,087 - $50,205	-134 Reduced 1.51%	8,735 $0
Q3 2022 Oct 18, 2022	SELL	$296.48 - $337.87 $170,476 - $194,275	-575 Reduced 6.09%	8,869 $2.87 Million
Q2 2022 Jul 22, 2022	BUY	$278.73 - $327.27 $37,628 - $44,181	135 Added 1.45%	9,444 $3.06 Million
Q1 2022 May 04, 2022	BUY	$234.69 - $291.66 $205,119 - $254,910	874 Added 10.36%	9,309 $2.67 Million
Q4 2021 Jan 25, 2022	BUY	$224.85 - $279.04 $180,779 - $224,348	804 Added 10.54%	8,435 $2.33 Million
Q3 2021 Oct 20, 2021	BUY	$221.6 - $272.71 $131,630 - $161,989	594 Added 8.44%	7,631 $1.76 Million
Q2 2021 Jul 30, 2021	BUY	$180.55 - $233.54 $133,787 - $173,053	741 Added 11.77%	7,037 $1.62 Million
Q1 2021 Apr 19, 2021	BUY	$164.32 - $212.72 $116,502 - $150,818	709 Added 12.69%	6,296 $1.18 Million
Q4 2020 Jan 27, 2021	BUY	$130.46 - $172.63 $75,666 - $100,125	580 Added 11.58%	5,587 $943,000
Q3 2020 Oct 30, 2020	BUY	$146.22 - $169.13 $732,123 - $846,833	5,007 New	5,007 $741,000

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $749B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Argus Investors' Counsel, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Argus Investors' Counsel, Inc. with notifications on news.

Account

Argus Investors' Counsel, Inc. Eli Lilly & CO Transaction History